Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization AVTX - Avalo Therapeutics, Inc.
158 K
LAST VALUE
-69.12%
2 YEAR CAGR
-48.95%
5 YEAR CAGR
22.94%
10 YEAR CAGR